equine vaccines

Edited press release Grayson-Jockey Club Research Foundation has issued a formal call for research applications focused on the development of a nucleic acid-based vaccine against equine herpes virus (EHV). Dr. John Ballantyne and Fargo-Moorhead Area Foundation have committed $2 million to fund this research. "We are so grateful to Dr. Ballantyne for his generosity in supporting efforts to address EHV, a disease that affects all horses," said Dell Hancock, chair of the foundation. "This gift will enable Grayson to continue its commitment to funding critical research for horses, and our...

The Thoroughbred Retirement Foundation (TRF) has been gifted more than 500 essential equine vaccines from Boehringer Ingelheim Animal Health. The vaccines will be used to innoculate retired horses in the TRF's care. "Helping organizations like the Thoroughbred Retirement Foundation is at the core of what we do," said Steve Boren, vice president of the U.S. livestock and equine businesses at Boehringer Ingelheim Animal Health. "We are honored to support an organization that makes a difference in the lives of horses." According to TRF board member Anita Motion, TRF is working...